A Molecular Switch‐Integrated Nanoplatform Enables Photo‐Unlocked Antibacterial Drug Delivery for Synergistic Abscess Therapy
Authors:
- 9 July 2023
- journal article
- research article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 12 (27) , e2301157
Abstract
Drug delivery systems (DDSs) capable of sequential multistage drug release are urgently needed for antibacterial applications. Herein, a molecular switch‐integrated, photo‐responsive nanoplatform is reported based on hollow mesoporous silica nanospheres (HMSN) loaded with silver nanoparticles (Ag NPs), vancomycin (Van), and hemin (HAVH) for bacteria elimination and abscess therapy. Upon near‐infrared (NIR) light irradiation, the molecular switch, hemin, can effuse from the mesopores of HMSN, triggering the release of pre‐loaded Ag+ and Van, which enables photothermal‐modulated drug release and synergistic photothermal‐chemo therapy (PTT‐CHT). The HAVH_NIR irreversibly disrupts the bacterial cell membrane, facilitating the penetration of Ag+ and Van. It is found that these compounds restrain the transcription and translation of ribosomes and lead to rapid bacterial death. Furthermore, hemin can effectively inhibit excessive inflammatory responses associated with the treatment, promoting accelerated wound healing in a murine abscess model. This work presents a new strategy for antibacterial drug delivery with high controllability and extendibility, which may benefit the development of smart multifunctional nanomedicine for diseases not limited to bacterial infections.Keywords
Funding Information
- National Natural Science Foundation of China (32160038, 32260020, 32000089, 31960027)
This publication has 59 references indexed in Scilit:
- Temperature-feedback upconversion nanocomposite for accurate photothermal therapy at facile temperatureNature Communications, 2016
- In Vitro Pharmacodynamics of Human Simulated Exposures of Telavancin against Methicillin-Susceptible and -Resistant Staphylococcus aureus with and without Prior Vancomycin ExposureAntimicrobial Agents and Chemotherapy, 2016
- Glycopeptide Antibiotic To Overcome the Intrinsic Resistance of Gram-Negative BacteriaACS Infectious Diseases, 2015
- Enzyme dimension of the ribosomal protein S4 across plant and animal kingdomsBiochimica et Biophysica Acta (BBA) - General Subjects, 2013
- Effects of Bacteriocins on Methicillin-Resistant Staphylococcus aureus BiofilmAntimicrobial Agents and Chemotherapy, 2013
- Plasmon-Modulated Light Scattering from Gold Nanocrystal-Decorated Hollow Mesoporous Silica MicrospheresACS Nano, 2010
- Comparative effectiveness of antibiotics for the treatment of MRSA complicated skin and soft tissue infectionsCurrent Medical Research and Opinion, 2010
- Reduced Vancomycin Susceptibility inStaphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical ImplicationsClinical Microbiology Reviews, 2010
- Ribosomal protein L20 controls expression of the Bacillus subtilis infC operon via a transcription attenuation mechanismNucleic Acids Research, 2007
- Staphylococcus aureus with Reduced Susceptibility to VancomycinClinical Infectious Diseases, 2004